MedPath

Clinical trial of central randomized, double-blind, dose exploration, multi-center, and two-stage adaptive design to evaluate the immediate pain relief effect and safety caused by pediatric acute pharyngitis (wind heat syndrome)

Phase 1
Recruiting
Conditions
Treatment of acute pharyngitis in children
Registration Number
ITMCTR2200005988
Lead Sponsor
The Teaching Hospital of Tianjin University of TCM
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the western diagnostic criteria for acute pharyngitis. 2.It conforms to the standard of wind-heat syndrome differentiation. 3.Duration =2 days. 4.VAS score =4 at initial diagnosis of sore throat (dysphagia). 5.Children aged 6-13 years (< 14 years) can correctly use VAS scoring tools.
6.The informed consent process should comply with the regulations, and the legal guardian or the subject child (=8 years old) should sign the informed consent.

Exclusion Criteria

1. Children or their parents/caregivers have difficulty in understanding or cooperating with the use of VAS. 2. At the time of initial diagnosis, the condition of the child is serious, such as lack of energy, restlessness, headache, or pain in body muscles, and antipyretic and analgesic drugs are needed. 3. Suppurative tonsillitis, abscess around tonsil or posterior pharyngeal wall, or white blood cell count, absolute value of neutrophil and CRP > ULN, which were considered to be caused by bacterial infection. 4.Children with measles, scarlet fever and other infectious diseases. 5.Children with acute laryngitis, otitis media, bronchitis, pneumonia and other complications. 6. Children with serious primary diseases of heart, lung, liver, kidney, metabolism, hematopoietic, immune, nervous, mental and other systems. 7. Allergic to the test drug (compound Solidago solidago spray) and its components, and allergic to antipyretic analgesics. 8.Patients who had taken acetaminophen, ibuprofen and other antipyretic and analgesic drugs within 6 hours before enrollment. 9.According to the judgment of the researcher, it is not suitable to be included in the group

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
pharyngeal pain;
Secondary Outcome Measures
NameTimeMethod
Effective rate of pharyngeal signs;Disappearance time/disappearance rate of pharyngeal pain.;TCM syndrome effect.;Recovery rates.;VAS score for sore throat.;Time and duration of immediate analgesic effect.;
© Copyright 2025. All Rights Reserved by MedPath